CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health centene Corporation (CNC) — Medical Costs ($M)
Annual figures from Cvs Health's filings and investor materials
Latest, FY2025
157,702
Period ended Dec 31, 2025
Change on a year earlier
+25.5%
125,707 in FY2024
History
10 years
Since FY2016
Sources
1
Centene Corp. SEC 10-K (XBRL)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Centene Corporation (CNC) — Medical Costs ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 157,702 | +25.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 125,707 | +5.7% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 118,894 | +6.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 111,529 | +13.1% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 98,602 | +14.3% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 86,264 | +46.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2019 | Dec 31, 2019 | 58,862 | +27.8% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2018 | Dec 31, 2018 | 46,057 | +21.7% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2017 | Dec 31, 2017 | 37,851 | +23.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| FY2016 | Dec 31, 2016 | 30,636 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
Cite this data
StockData. (2026). Cvs Health Centene Corporation (CNC) — Medical Costs ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_cnc_benefits
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.